Liminatus Pharma Inc. Class A Common Stock (LIMN) Statistics & Valuation Metrics - Stocknear

Liminatus Pharma Inc. Cla...

NASDAQ: LIMN · Real-Time Price · USD
2.31
-0.36 (-13.48%)
At close: Sep 08, 2025, 3:59 PM
2.44
5.59%
After-hours: Sep 08, 2025, 07:58 PM EDT

Liminatus Pharma Class A Common Stock Statistics

Share Statistics

Liminatus Pharma Class A Common Stock has 27.06M shares outstanding. The number of shares has increased by null% in one year.

27.06M
n/a
n/a
n/a
n/a
153,103
12.14%

Short Selling Information

The latest short interest is 273.66K, so 0% of the outstanding shares have been sold short.

273.66K
n/a
n/a
1

Valuation Ratios

The PE ratio is -88962.88 and the forward PE ratio is null. Liminatus Pharma Class A Common Stock's PEG ratio is -533.78.

-88962.88
n/a
0
n/a
-2.27
-11.6
-533.78
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Liminatus Pharma Class A Common Stock.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 0.09, with a Debt / Equity ratio of -0.32.

0.09
0.09
-0.32
-12.65K
-1.65
-21.04

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-135
3
0
n/a

Taxes

18.84K
-0.65%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.47, so Liminatus Pharma Class A Common Stock's price volatility has been higher than the market average.

0.47
n/a
5.39
n/a
32.13
1,261,406

Income Statement

n/a
n/a
-2.91M
-405
-405
-2.75M
-0.4
Full Income Statement

Balance Sheet

The company has 804.54K in cash and 5.12M in debt, giving a net cash position of -4.32M.

804.54K
5.12M
-4.32M
-17.52M
n/a
n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.11M and capital expenditures 0, giving a free cash flow of -3.11M.

-3.11M
n/a
-3.11M
-0.43
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

LIMN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for LIMN.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

n/a
n/a